Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel antivascular efficacy of metronomic docetaxel therapy in prostate cancer: hnRNP K as a player.

International journal of cancer - 15 Jun 2009

Benelli Roberto, Monteghirfo Stefano, Balbi Cecilia, Barboro Paola, Ferrari Nicoletta

Abstract excerpt

Tumor growth requires a competent vascular supply and angiogenesis is now considered a potential target for cancer treatment. Chemotherapeutic drugs, and docetaxel in particular, chronically administered using a frequent schedule at low dose (metronomic dosing), can cause potent antiangiogenic ef...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Chemotaxis
Share to Docetaxel

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunoenzyme Techniques

Share to Neoplasm Invasiveness

Share to Neovascularization, Pathologic

Share to Taxoids

Share to Thrombospondin 1

Source

Identifiers

PMID: 19319982
DOI: 10.1002/ijc.24305

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19319982-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Novel antivascular efficacy of metronomic docetaxel therapy in prostate cancer: hnRNP K as a player.PMID 19319982Read ↗

Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models.Semantic proximity Read ↗

Hypoxia-associated p38 mitogen-activated protein kinase-mediated androgen receptor activation and increased HIF-1alpha levels contribute to emergence of an aggressive phenotype in prostate cancer.Semantic proximity Read ↗

Genetic signature of prostate cancer resistant to optimized hK2 targeted alpha-particle therapySemantic proximity Read ↗

Heterogeneous Nuclear Ribonucleoprotein K Is a Novel Regulator of Androgen Receptor TranslationSemantic proximity Read ↗

Precision Targets for Intercepting the Lethal Progression of Prostate Cancer: Potential Avenues for Personalized TherapySemantic proximity Read ↗

Prostate cancer heterogeneity: Discovering novel molecular targets for therapySemantic proximity Read ↗

Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy.Semantic proximity Read ↗

Exploration and Identification of Potential Therapeutic Targets and Biomarkers for Docetaxel Resistant Prostate CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.